FBLN2 is associated with Goldenhar syndrome and is essential for cranial neural crest cell development
Annals of the New York Academy of Sciences · 2024
DOI: 10.1111/nyas.15183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the New York Academy of Sciences, 2024. Verfasst von Xiaomin Niu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P…. Hauptthemen laut MEDLINE: Zebrafish, Neural Crest, Goldenhar Syndrome, Pedigree. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Goldenhar syndrome, a rare craniofacial malformation, is characterized by developmental anomalies in the first and second pharyngeal arches. Its etiology is considered to be heterogenous, including both genetic and environmental factors that remain largely unknown. To further elucidate the genetic cause in a five‐generation Goldenhar syndrome pedigree and exploit the whole‐exome sequencing (WES) data of this pedigree, we generated collapsed haplotype pattern markers based on WES and employed rare variant nonparametric linkage analysis. FBLN2 was identified as a candidate gene via analysis of WES data across the significant linkage region. A fbln2 knockout zebrafish line was established by CRISPR/Cas9 to examine the gene's role in craniofacial cartilage development. fbln2 was expressed specifically in the mandible during the zebrafish early development, while fbln2 knockout zebrafish exhibited craniofacial malformations with abnormal chondrocyte morphologies. Functional studies revealed that fbln2 knockout caused abnormal chondrogenic differentiation, apoptosis, and proliferation of cranial neural crest cells (CNCCs), and downregulated the bone morphogenic protein (BMP) signaling pathway in the zebrafish model. This study demonstrates the role of FBLN2 in CNCC development and BMP pathway regulation, and highlights FBLN2 as a candidate gene for Goldenhar syndrome, which may have implications for the selection of potential screening targets and the development of treatments for conditions like microtia‐atresia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
- 8-Year MD Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
- Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education, College of Life Sciences, Peking University, Beijing, People's Republic of China.
ORCID-Profile: Fuyu Zhang
Förderung
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
Zitieren
APA
Niu, X., Zhang, F., Gu, W., Zhang, B., & Chen, X. (2024). FBLN2 is associated with Goldenhar syndrome and is essential for cranial neural crest cell development. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.15183
Vancouver
Niu X, Zhang F, Gu W, Zhang B, Chen X. FBLN2 is associated with Goldenhar syndrome and is essential for cranial neural crest cell development. Annals of the New York Academy of Sciences. 2024. doi:10.1111/nyas.15183
BibTeX
@article{Niu2024,
author = {Niu, Xiaomin and Zhang, Fuyu and Gu, Wei and Zhang, Bo and Chen, Xiaowei},
title = {FBLN2 is associated with Goldenhar syndrome and is essential for cranial neural crest cell development},
journal = {Annals of the New York Academy of Sciences},
year = {2024},
doi = {10.1111/nyas.15183}
}
EUVIMED